We are live on ! Find out more

Large Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
NVO
1
Novo Nordisk
NVO
$190B
$190B $43.07 2.14%
GILD icon
2
Gilead Sciences
GILD
$178B
$178B $143.72 0.75%
ABT icon
3
Abbott
ABT
$176B
$176B $101.95 1.36%
PFE icon
4
Pfizer
PFE
$158B
$158B $27.72 0.25%
DHR icon
5
Danaher
DHR
$141B
$141B $200.14 0.19%
VRTX icon
6
Vertex Pharmaceuticals
VRTX
$131B
$131B $515.44 0.17%
ISRG icon
7
Intuitive Surgical
ISRG
$130B
$130B $369.15 2.41%
BMY icon
8
Bristol-Myers Squibb
BMY
$130B
$130B $63.64 0.17%
CVS icon
9
CVS Health
CVS
$121B
$121B $94.66 0.66%
MDT icon
10
Medtronic
MDT
$116B
$116B $90.96 0.72%
SYK icon
11
Stryker
SYK
$106B
$106B $275.56 2.06%
MCK icon
12
McKesson
MCK
$103B
$103B $881.51 0.07%
SNY icon
13
Sanofi
SNY
$102B
$102B $42.77 0.12%
GSK icon
14
GSK
GSK
$96.4B
$96.4B $48.13 0.02%
HCA icon
15
HCA Healthcare
HCA
$92.4B
$92.4B $426.94 1.36%
ELV icon
16
Elevance Health
ELV
$90.8B
$90.8B $418.72 0.52%
REGN icon
17
Regeneron Pharmaceuticals
REGN
$80.5B
$80.5B $781.49 1.48%
CI icon
18
Cigna
CI
$74.2B
$74.2B $280.76 0.05%
BSX icon
19
Boston Scientific
BSX
$62.3B
$62.3B $42.98 0.28%
ARGX icon
20
argenx
ARGX
$61.6B
$61.6B $984.39 0.04%
COR icon
21
Cencora
COR
$61.4B
$61.4B $321.57 0.19%
TAK icon
22
Takeda Pharmaceutical
TAK
$58.3B
$58.3B $18.26 0.83%
MRNA icon
23
Moderna
MRNA
$57.5B
$57.5B $143.97 5.38%
CAH icon
24
Cardinal Health
CAH
$54.6B
$54.6B $234.57 0.61%
HUM icon
25
Humana
HUM
$49.2B
$49.2B $409.80 2.26%
1
2 3 4 5

Large Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 105 large cap Healthcare stocks — companies in the Healthcare sector with a market cap between $10B and $200B — worth a combined $4.39T.

The largest by market cap are Novo Nordisk (NVO) at $190B, Gilead Sciences (GILD) at $178B and Abbott (ABT) at $176B.

Among institutional investors, CVS Health (CVS) drew the most net new fund positions in Q2 2026: 322 funds opened new positions, taking total fund holders up 189 (10%) quarter-over-quarter.

  • Combined market cap: $4.39T across 105 stocks.
  • Large Cap: market cap between $10B and $200B.
  • Largest constituent: Novo Nordisk (NVO), $190B market cap.
  • Most net new fund positions in Q2 2026: CVS Health (CVS), +189 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.